🚀 VC round data is live in beta, check it out!
- Public Comps
- Optiscan Imaging
Optiscan Imaging Valuation Multiples
Discover revenue and EBITDA valuation multiples for Optiscan Imaging and similar public comparables like Senzime, Genasys, Outset Medical, AOTI and more.
Optiscan Imaging Overview
About Optiscan Imaging
Optiscan Imaging Ltd is engaged in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications. Its technology offers real-time, 3D, in vivo imaging at the single-cell level, in a non-destructive manner that enables clinicians to make immediate informed decisions. Its products include InVivage, ViewnVivo, and Customisation. Its geographical segments include Australia, Germany, Norway, China, and the United States.
Founded
1997
HQ

Employees
33
Website
Financials (FY)
EV
$70M
Valuation Multiples
Start free trialOptiscan Imaging Financials
Optiscan Imaging reported last fiscal year revenue of $679K and negative EBITDA of ($4M).
In the same fiscal year, Optiscan Imaging generated $342K in gross profit, ($4M) in EBITDA losses, and had net loss of ($5M).
Optiscan Imaging P&L
In the most recent fiscal year, Optiscan Imaging reported revenue of $679K and EBITDA of ($4M).
Optiscan Imaging is unprofitable as of last fiscal year, with gross margin of 50%, EBITDA margin of (613%), and net margin of (663%).
Financial data powered by Morningstar, Inc.
Optiscan Imaging Stock Performance
Optiscan Imaging has current market cap of $82M, and enterprise value of $70M.
Market Cap Evolution
Optiscan Imaging's stock price is $0.08.
Optiscan Imaging share price decreased by 25.9% in the last year.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $70M | $82M | 3.9% | — | 25.6% | -25.9% | $-0.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialOptiscan Imaging Valuation Multiples
Optiscan Imaging trades at 103.6x EV/Revenue multiple, and (16.9x) EV/EBITDA.
Optiscan Imaging Financial Valuation Multiples
As of May 1, 2026, Optiscan Imaging has market cap of $82M and EV of $70M.
Optiscan Imaging has a P/E ratio of (18.2x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Optiscan Imaging Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Optiscan Imaging Margins & Growth Rates
In the most recent fiscal year, Optiscan Imaging reported gross margin of 50%, EBITDA margin of (613%), and net margin of (663%).
Optiscan Imaging Margins
Optiscan Imaging Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Optiscan Imaging Operational KPIs
Optiscan Imaging's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.2M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Optiscan Imaging Competitors
Optiscan Imaging competitors include Senzime, Genasys, Outset Medical, AOTI, Meditera, Agfa-Gevaert, SomnoMed, Sera Prognostics, BioStem Technologies and Austco Healthcare.
Most Optiscan Imaging public comparables operate across Medical Devices, Test & Measurement, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 6.4x | 5.6x | (6.7x) | (8.2x) | |||
| 2.2x | 1.5x | (7.3x) | (77.9x) | |||
| 0.1x | 0.1x | (0.2x) | (0.3x) | |||
| 1.3x | — | 11.5x | — | |||
| 1.1x | — | 15.4x | — | |||
| 0.1x | 0.1x | 2.6x | 2.6x | |||
| 1.0x | 0.9x | 13.2x | 10.2x | |||
| 482.8x | 187.2x | (1.3x) | (1.1x) | |||
This data is available for Pro users. Sign up to see all Optiscan Imaging competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Optiscan Imaging
| When was Optiscan Imaging founded? | Optiscan Imaging was founded in 1997. |
| Where is Optiscan Imaging headquartered? | Optiscan Imaging is headquartered in Australia. |
| How many employees does Optiscan Imaging have? | As of today, Optiscan Imaging has over 33 employees. |
| Is Optiscan Imaging publicly listed? | Yes, Optiscan Imaging is a public company listed on Australian Securities Exchange. |
| What is the stock symbol of Optiscan Imaging? | Optiscan Imaging trades under OIL ticker. |
| When did Optiscan Imaging go public? | Optiscan Imaging went public in 1997. |
| Who are competitors of Optiscan Imaging? | Optiscan Imaging main competitors include Senzime, Genasys, Outset Medical, AOTI, Meditera, Agfa-Gevaert, SomnoMed, Sera Prognostics, BioStem Technologies, Austco Healthcare. |
| What is the current market cap of Optiscan Imaging? | Optiscan Imaging's current market cap is $82M. |
| What is the current revenue of Optiscan Imaging? | Optiscan Imaging's last fiscal year revenue is $679K. |
| What is the current EV/Revenue multiple of Optiscan Imaging? | Current revenue multiple of Optiscan Imaging is 103.6x. |
| Is Optiscan Imaging profitable? | No, Optiscan Imaging is not profitable. |
| How many companies Optiscan Imaging has acquired to date? | Optiscan Imaging hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Optiscan Imaging has invested to date? | Optiscan Imaging hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Optiscan Imaging
Lists including Optiscan Imaging
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.